For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Dexcom, Inc.

USPTO Granted Patents = 970

CIPO Patents = 7

EPO Patents = 206

Trademarks = 14

Forward Citations = 71,833

Loading Chart...

Loading Chart...

414 inventors (with patents filed for the assignee):

Apurv Ullas Kamath (371 out of 382 patents)

Peter C Simpson (302 out of 305 patents)

James H Brauker (265 out of 267 patents)

4. Michael Robert Mensinger (151 out of 167 patents)

5. Paul V Goode, Jr (149 out of 179 patents)

6. Mark C Brister (141 out of 191 patents)

7. Eli Reihman (121 out of 122 patents)

8. Katherine Yerre Koehler (109 out of 109 patents)

9. Hari Hampapuram (97 out of 97 patents)

10. Rian W Draeger (97 out of 97 patents)

11. Aarthi Mahalingam (95 out of 95 patents)

12. Eric Cohen (91 out of 100 patents)

13. James Patrick Thrower (89 out of 95 patents)

14. Paul V Neale (88 out of 91 patents)

15. Jack Pryor (84 out of 113 patents)

Core Competencies:

Wireless Communication

Glucose Monitoring

Machine Learning

Analyte Sensors

Insulin Delivery Systems

Data Analytics

Temperature Compensation

Remote Monitoring

Predictive Alerts

Battery Management

Calibration Techniques

Transcutaneous Sensors

970 patents: Sort by Forward Citations

1. 12507913 - Apparatuses, systems, and methods of improving patch performance for a medical device (2025-12-30),

2. 12507892 - Remote monitoring of analyte measurements (2025-12-30),

3. 12502108 - Implantable sensor devices, systems, and methods (2025-12-23),

4. 12502107 - Systems, devices, and methods to compensate for temperature effects on sensors (2025-12-23),

5. 12502103 - Systems for determining similarity of sequences of glucose values (2025-12-23),

6. 12495996 - Analyte sensor electrode arrangements (2025-12-16),

7. 12490919 - Applicators for applying transcutaneous analyte sensors and associated methods of manufacture (2025-12-09),

8. 12484778 - System and method for wireless communication of glucose data (2025-12-02),

9. 12478331 - Glucose alert prediction horizon modification (2025-11-25),

10. 12478298 - Systems, devices, and methods to compensate for temperature effects on sensors (2025-11-25),

11. 12471849 - Systems, devices and methods for analyte monitoring system (2025-11-18),

12. 12458753 - Managing bolus doses (2025-11-04),

13. 12458253 - Machine learning in an artificial pancreas (2025-11-04),

14. 12456239 - Integrated medicament delivery device for use with continuous analyte sensor (2025-10-28),

15. 12444508 - Detection of anomalous computing environment behavior using glucose (2025-10-14),

DexCom, Inc. is a leading provider of continuous glucose monitoring (CGM) systems for diabetes management. They develop and market innovative CGM systems that help patients and healthcare professionals effectively manage diabetes. DexCom's CGM technology enables real-time monitoring of glucose levels, allowing patients to make informed decisions about their treatment and improve overall diabetes control. With a commitment to advancing diabetes care, DexCom focuses on developing innovative solutions to improve the lives of people with diabetes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

970 Patents

#4 in San Diego, CA

#127 in California

#517 in US

#1,027 in the World

San Diego, CA, United States of America

Dexcom, Inc.

Forward Citations = 71,833

414 inventors:

Apurv Ullas Kamath (371 out of 382 patents)

Peter C Simpson (302 out of 305 patents)

James H Brauker (265 out of 267 patents)

4. Michael Robert Mensinger (151 out of 167 patents)

5. Paul V Goode, Jr (149 out of 179 patents)

Please report any incorrect information to support@idiyas.com

Loading…